Montelukast Prescribing at MARKET CROSS SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,122
Total Quantity
29.6K
NHS Cost
£1.6K
vs National Avg
+63.9%
MARKET CROSS SURGERY prescribed 1,122 items of Montelukast over the last 12 months at a cost of £1,605 to the NHS. This is 63.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
103
Jul 2026
91
Jul 2026
100
Jul 2026
84
Jul 2026
89
Jul 2026
98
Jul 2026
97
Jul 2026
96
Jul 2026
98
Jul 2026
85
Jul 2026
83
Jul 2026
98
Prescribing Details
| Total Items | 1,122 |
|---|---|
| Total Quantity | 29,624 |
| Total NHS Cost | £1,605 |
| Presentations | 4 different forms |
| vs National Average | +63.9% |
Montelukast Prescribing Comparison
| This practice | 1,122 items |
|---|---|
| National average per practice | 685 items |
| Difference | +63.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.